Advertisement
Screener

FITLIFE BRANDS, INC. (FTLF) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

FITLIFE BRANDS, INC. Stock-Based Compensation

FITLIFE BRANDS, INC. (FTLF) reported Stock-Based Compensation of $17.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-05-14

  • FITLIFE BRANDS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $17.00K, a 84.11% decline year-over-year.
  • FITLIFE BRANDS, INC. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $107.00K.
  • FITLIFE BRANDS, INC. share-based payment arrangement, expense for the quarter ending 2020-12-31 was $34.00K.
  • FITLIFE BRANDS, INC. share-based payment arrangement, expense for the quarter ending 2020-09-30 was $5.00K, a 78.26% decline year-over-year.
  • FITLIFE BRANDS, INC. share-based payment arrangement, expense for fiscal 2022 was $76.00K, a 24.00% decline from fiscal 2021.
  • FITLIFE BRANDS, INC. share-based payment arrangement, expense for fiscal 2021 was $100.00K, a 58.73% increase from fiscal 2020.
  • FITLIFE BRANDS, INC. share-based payment arrangement, expense for fiscal 2020 was $63.00K.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 3 month as first filedShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 6 month as first filedShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 9 month as first filedShare-based Payment Arrangement, Expense 12 month
2026-03-31$17.00K
10-Q · filed 2026-05-14
2025-03-31$107.00K
10-Q · filed 2026-05-14
2022-12-31$76.00K
10-K · filed 2023-03-24
2021-12-31$100.00K
10-K · filed 2023-03-24
2020-12-31$34.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-10-13
$39.00K
derived: sum of 2 quarters · filed 2022-10-13
$51.00K
derived: sum of 3 quarters · filed 2022-10-13
$63.00K
10-K/A · filed 2022-10-13
2020-09-30$5.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$17.00K
derived: sum of 2 quarters · filed 2020-11-12
$29.00K
10-Q · filed 2020-11-12
2020-06-30$12.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
$24.00K
10-Q · filed 2020-08-13
2020-03-31$12.00K
10-Q · filed 2020-05-15
2019-09-30$23.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$68.00K
derived: sum of 2 quarters · filed 2020-11-12
$94.00K
10-Q · filed 2020-11-12
2019-06-30$45.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
$71.00K
10-Q · filed 2020-08-13
2019-03-31$26.00K
10-Q · filed 2020-05-15
2018-09-30$14.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$32.00K
derived: sum of 2 quarters · filed 2019-11-12
$33.00K
10-Q · filed 2019-11-12
$85.00K
10-Q · filed 2018-11-14
2018-06-30$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$19.00K
10-Q · filed 2019-08-09
2018-03-31$1.00K
10-Q · filed 2019-05-15
$10.46K
10-Q · filed 2018-05-15
2017-09-30$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$21.42K
derived: sum of 2 quarters · filed 2018-11-14
$33.00K
10-Q · filed 2018-11-14
$33.47K
10-Q · filed 2017-11-14
2017-06-30$11.42K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$23.00K
10-Q · filed 2018-08-14
$23.14K
10-Q · filed 2017-08-21
2017-03-31$11.58K
10-Q · filed 2018-05-15
2016-09-30$41.05K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$45.03K
10-Q · filed 2017-11-14
2016-06-30$3.98K
10-Q · filed 2017-08-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87